Manuela Merli

Pubblicazioni

Titolo Pubblicato in Anno
A Comparative Study of Dietary Intake, Nutritional Status, and Frailty in Outpatients and Inpatients with Liver Cirrhosis NUTRIENTS 2025
Management of ascites in elderly patients with cirrhosis: Results of an Italian survey DIGESTIVE AND LIVER DISEASE 2025
Pediatric liver and kidney transplant recipients demonstrate greater serological response to sars-cov-2 vaccination than adults TRANSPLANTATION DIRECT 2025
Sex differences in hepatic encephalopathy: addressing the knowledge gap DIGESTIVE AND LIVER DISEASE 2025
The impact of bacterial infection on the risk of portal vein thrombosis development in patients with cirrhosis: a post-hoc analysis DIGESTIVE AND LIVER DISEASE 2025
Study protocol to redefine muscle attenuation cut-offs for better prediction of mortality in patients with cirrhosis: a comprehensive post hoc validation study – a study protocol BMJ OPEN 2025
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study THE LANCET. GASTROENTEROLOGY & HEPATOLOGY 2025
Circulating extracellular vesicles in alcoholic liver disease affect skeletal muscle homeostasis and differentiation JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE 2025
Sarcopenia As a Predictor of Survival and Complications of Patients With Cirrhosis After Liver Transplantation: A Systematic Review and Meta‐Analysis CLINICAL TRANSPLANTATION 2025
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosis HEPATOLOGY 2025
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting JOURNAL OF CLINICAL MEDICINE 2024
Evolution of transplant oncology indications: a single-institution experience over 40 years UPDATES IN SURGERY 2024
Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis JOURNAL OF CLINICAL MEDICINE 2024
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis JOURNAL OF HEPATOLOGY 2024
Reply to: “Reevaluating myosteatosis criteria in cirrhosis: Fluid and gender considerations” JOURNAL OF HEPATOLOGY 2024
Reply to: “What references and what gold standard should be used to assess myosteatosis in chronic liver disease?” JOURNAL OF HEPATOLOGY 2024
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis JOURNAL OF HEPATOLOGY 2024
Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial LIVER INTERNATIONAL 2024
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study) HEPATOLOGY 2024
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements HEPATOLOGY 2024

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma